Skip to main content
Register
Medicine Matters Diabetes
SEARCH
Menu 1 2 3 4

Addressing suicide risk in diabetes

Rates and risk factors, HCP fears, and practical advice

What you need to know

The increased risk for suicide in people with diabetes was recently flagged by the US FDA as an understudied topic of vital importance.


Browse this page to learn about rates and risk, underlying psychological factors, practical actions that healthcare providers can take to support patients, and the goals of the RESCUE Collaborative Community.

Suicide risk in diabetes: Why doctors may hesitate to screen, but should not

Mary de Groot explains the importance of screening for suicidal ideation in people with diabetes, and addresses common concerns that may make doctors hesitate to do so (7:22).


Watch the video

External Content

Click Play to display this content and agree to third party cookies. (>)

Update your current cookie settings.

Addressing suicide risk in diabetes

07-14-2021 | Mental health | Feature | Article

Suicide in diabetes: An important but under-recorded problem

How frequent are suicide deaths in people with diabetes, and can the data be trusted?

07-14-2021 | Mental health | Feature | Article

Risk for suicidal ideation: Who, when, and why?

What makes some people more likely than others to have suicidal thoughts? We outline the risk factors and circumstances that can play a role.

07-14-2021 | Mental health | Feature | Article

Creating a safety net: How doctors can help suicidal patients

Screening, emergency protocols, and person-centered care – just some of the ways healthcare professionals can identify and support people at increased risk for suicide. Click through for more.

An international collaborative community to address suicide risk in diabetes

Katharine Barnard-Kelly explains how the international RESCUE Collaborative Community, in partnership with the US FDA, aims to raise awareness of the risk for suicide in people with diabetes, improve data-gathering, and provide support for people at risk and their healthcare providers (2:25).


Watch the video

External Content

Click Play to display this content and agree to third party cookies. (>)

Update your current cookie settings.

About the contributors

Mary de Groot

Mary de Groot, PhD, is an Associate Professor of Medicine and acting director of the Diabetes Translational Research Center at Indiana University. Browse contributions

Katharine Barnard-Kelly

Katharine Barnard-Kelly, PhD, is Professor of Health Psychology, specializing in the psychosocial impact and management of illness and long-term conditions. Browse contributions

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

Sign up for the e-alert today
Image Credits